ConductScience.org, home

Paper39598554

Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management.

Lee KR and 2 others. Pharmaceutics, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management. Papers, record 39598554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39598554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management.
PubMed
Journal
Pharmaceutics
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.46, provisional
iCite
Revised in PubMed
2024-11-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee KRKyeong-Ryoonhttps://orcid.org/0000-0003-2175-8876
2Gulnaz AAneela
3Chae YJYoon-Jeehttps://orcid.org/0000-0003-4921-4192

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2021R1I1A3056261National Research Foundation of KoreaPubMed
NAKRIBB Research Initiative ProgramPubMed

Source PubMed

Download CSV of grants

References138

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116686369Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse.Mol Pharm2006https://conductscience.org/library/papers/16686369PubMed
217553913Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: a mechanism for possible drug interactions.Drug Metab Dispos2007https://conductscience.org/library/papers/17553913PubMed
310389134Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers.Pediatr Transplant1999https://conductscience.org/library/papers/10389134PubMed
428730856In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes.Xenobiotica2018https://conductscience.org/library/papers/28730856PubMed
516128682Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.Aliment Pharmacol Ther2005https://conductscience.org/library/papers/16128682PubMed
623128233Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.Nature2012https://conductscience.org/library/papers/23128233PubMed
722169051
Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study.
Clin Ther2012https://conductscience.org/library/papers/22169051PubMed
819026171Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes.Acta Pharmacol Sin2008https://conductscience.org/library/papers/19026171PubMed
938050329Assessment of CYP3A-mediated drug interaction via cytokine (IL-6) elevation for mosunetuzumab using physiologically-based pharmacokinetic modeling.CPT Pharmacometrics Syst Pharmacol2024https://conductscience.org/library/papers/38050329PubMed
1028124606Cytochrome P450 Structure, Function and Clinical Significance: A Review.Curr Drug Targets2018https://conductscience.org/library/papers/28124606PubMed
11166330465-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.Inflamm Bowel Dis2006https://conductscience.org/library/papers/16633046PubMed
1227437405Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications.J Immunol Res2016https://conductscience.org/library/papers/27437405PubMed
1315819814Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).Transpl Int2005https://conductscience.org/library/papers/15819814PubMed
1434752478Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression.PLoS One2021https://conductscience.org/library/papers/34752478PubMed
1531945371AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.Gastroenterology2020https://conductscience.org/library/papers/31945371PubMed
1620393175Infliximab, azathioprine, or combination therapy for Crohn's disease.N Engl J Med2010https://conductscience.org/library/papers/20393175PubMed
1729409871Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.Gastroenterology2018https://conductscience.org/library/papers/29409871PubMed
186580097Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol.Clin Pharmacol Ther1983https://conductscience.org/library/papers/6580097PubMed
1932202190Effects of naringenin on the pharmacokinetics of tofacitinib in rats.Pharm Biol2020https://conductscience.org/library/papers/32202190PubMed
2011600468Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.Gut2001https://conductscience.org/library/papers/11600468PubMed

See all 138 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42819218Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective.Front Microbiol2026https://conductscience.org/library/papers/42819218PubMed
42745107Properties of Persea americana Mill (Lauraceae) kernels aqueous extract on acetic acid-induced ulcerative colitis in rats.Inflammopharmacology2026https://conductscience.org/library/papers/42745107PubMed
42186949Modulation of Oxidative Stress and Nuclear Factor-κB- Associated Inflammatory Signaling by Rabeprazole in Acetic Acid-Induced Colonic InjuryTurk J Gastroenterol2026https://conductscience.org/library/papers/42186949PubMed
41688589Drug-disease interactions in inflammation: mechanisms, clinical Impact, and future directions.Inflammopharmacology2026https://conductscience.org/library/papers/41688589PubMed
40088372The efficacy, safety, and persistence of vedolizumab versus adalimumab in patients with inflammatory bowel disease: a systematic review and meta-analysis.Inflammopharmacology2025https://conductscience.org/library/papers/40088372PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39598554

GET https://conductscience.org/api/papers/v1/39598554/references?page=2